Keytruda 100 MG/4 ML vial 4ML
Ended Awarded
- Contract number
- SPE2DX25F6AFT
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $1,181,398
Award facts
- Contract value 100% obligated
- $1,181,397.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order on September 10, 2025, valued at $1.18 million for the supply of Keytruda 100 mg/4 mL vials. This delivery order was issued without a set-aside designation and falls under the company's larger indefinite delivery contract with the Defense Logistics Agency's SPE2DB program, which carries a $500 million ceiling value and remains valid through November 2026. The Medical Supply Chain, operating under the Department of Defense, serves as the funding federal agency for this award, with the place of performance designated as Park Ridge, Illinois.
As a critical supplier within the federal pharmaceutical supply chain, DMS Pharmaceutical Group has established a substantial portfolio delivering oncology treatments, biologics, and specialty medications to military healthcare facilities nationwide. Keytruda, a checkpoint inhibitor immunotherapy used in cancer treatment, represents a significant pharmaceutical product within the company's ongoing support of Department of Defense medical supply operations. The delivery order is scheduled for ultimate completion by October 1, 2025, positioning the company to maintain its role as a key distributor of branded pharmaceutical products supporting military health system operations across the United States.
Quick answers
Who was awarded contract SPE2DX25F6AFT?
SPE2DX25F6AFT was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on September 10, 2025.
How much is contract SPE2DX25F6AFT worth?
The government has obligated $1,181,398 on SPE2DX25F6AFT.
Is contract SPE2DX25F6AFT an order under another contract?
Yes. SPE2DX25F6AFT is a delivery order under SPE2DX15D9114, an indefinite delivery contract.
Was contract SPE2DX25F6AFT competed?
The extent of competition for SPE2DX25F6AFT was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award